Here is how CVS Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for CVS Health here>>> Shares of CVS Health have returned -6.5% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Medical benefit ratio (MBR): 89.9% versus the seven-analyst average estimate of 9 ...